Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:51 am Sale | 2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Marshall Wace North America L.P. | 597,469 2.700% | -625,783 (-51.16%) | Filing History |
| 2023-05-22 4:15 pm Purchase | 2023-05-12 | 13G | InspireMD, Inc. NSPR | Marshall Wace North America L.P. | 1,860,405 9.900% | 1,860,405 (New Position) | Filing History |
| 2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Marshall Wace North America L.P. | 1,223,252 5.900% | 1,223,252 (New Position) | Filing History |